Work

Five-Year Survival in EGFR -Mutant Metastatic Lung Adenocarcinoma Treated with EGFR-TKIs

Year: 2015

Type: article

Study design: Observational Study

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2015.12.103

Authors: Jessica J. Lin, Stephanie Cardarella, Christine A. Lydon, Suzanne E. Dahlberg, David M. Jackman, Pasi A. Jänne, Bruce E. Johnson

Institutions: Brigham and Women's Hospital, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center, Rhode Island Hospital, Harvard University, Dana-Farber/Harvard Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Dana-Farber/Harvard Cancer Center, National Institutes of Health, National Cancer Institute

Awards: G458608165, G5106396711, G7495787839, G8400305590, G9000136306, G9000173041, G9000273081

OpenAlex ID: W2206185841

FWCI: 13.78

Cites: 51

Cited by: 356

Related to: 10